- Home
- MDXH vs AOMR Comparison
MDXH vs AOMR Comparison
Compare MDXH & AOMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXH
- AOMR
- Stock Information
- Founded
- MDXH 2003
- AOMR 2018
- Country
- MDXH Belgium
- AOMR United States
- Employees
- MDXH N/A
- AOMR N/A
- Industry
- MDXH
- AOMR Real Estate Investment Trusts
- Sector
- MDXH
- AOMR Real Estate
- Exchange
- MDXH Nasdaq
- AOMR Nasdaq
- Market Cap
- MDXH 203.4M
- AOMR 224.3M
- IPO Year
- MDXH 2021
- AOMR 2021
- Fundamental
- Price
- MDXH $4.92
- AOMR $9.07
- Analyst Decision
- MDXH Buy
- AOMR Strong Buy
- Analyst Count
- MDXH 1
- AOMR 6
- Target Price
- MDXH $6.00
- AOMR $11.25
- AVG Volume (30 Days)
- MDXH 274.6K
- AOMR 82.3K
- Earning Date
- MDXH 11-12-2025
- AOMR 11-06-2025
- Dividend Yield
- MDXH N/A
- AOMR 14.11%
- EPS Growth
- MDXH N/A
- AOMR N/A
- EPS
- MDXH N/A
- AOMR 1.56
- Revenue
- MDXH $98,953,000.00
- AOMR $57,661,000.00
- Revenue This Year
- MDXH $24.43
- AOMR N/A
- Revenue Next Year
- MDXH $21.00
- AOMR $12.91
- P/E Ratio
- MDXH N/A
- AOMR $5.80
- Revenue Growth
- MDXH 22.56
- AOMR N/A
- 52 Week Low
- MDXH $1.35
- AOMR $7.36
- 52 Week High
- MDXH $5.33
- AOMR $10.88
- Technical
- Relative Strength Index (RSI)
- MDXH 64.64
- AOMR 39.96
- Support Level
- MDXH $4.71
- AOMR $9.24
- Resistance Level
- MDXH $5.33
- AOMR $9.38
- Average True Range (ATR)
- MDXH 0.30
- AOMR 0.17
- MACD
- MDXH 0.05
- AOMR -0.01
- Stochastic Oscillator
- MDXH 72.11
- AOMR 15.27
About MDXH MDxHealth SA
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.
About AOMR Angel Oak Mortgage REIT Inc.
Angel Oak Mortgage REIT Inc is a real estate finance company focused on acquiring and investing in the first lien non-QM loans and other mortgage-related assets in the U.S. mortgage market. Its objective is to generate attractive risk-adjusted returns for its stockholders, through cash distributions and capital appreciation across interest rates and credit cycles.